Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to UK£5.70, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 24x in the Aerospace & Defense industry in the United Kingdom. Total returns to shareholders of 113% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at UK£6.35 per share. Declared Dividend • Jun 04
First half dividend increased to UK£0.028 Dividend of UK£0.028 is 3.7% higher than last year. Ex-date: 13th August 2026 Payment date: 4th September 2026 Dividend yield will be 1.6%, which is lower than the industry average of 2.1%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 6.9% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 74% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Jun 02
First half 2026 earnings released: EPS: UK£0.051 (vs UK£0.074 in 1H 2025) First half 2026 results: EPS: UK£0.051 (down from UK£0.074 in 1H 2025). Revenue: UK£237.3m (up 6.5% from 1H 2025). Net income: UK£14.2m (down 30% from 1H 2025). Profit margin: 6.0% (down from 9.1% in 1H 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Aerospace & Defense industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 20% per year. Announcement • May 26
Chemring Group PLC to Report First Half, 2026 Results on Jun 02, 2026 Chemring Group PLC announced that they will report first half, 2026 results on Jun 02, 2026 Board Change • May 20
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Senior Independent Director Baroness Rock was the last director to join the board, commencing their role in 2026. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • Mar 05
Chemring Group plc Announces Appointment of Baroness Kate Rock as Independent Non-Executive Director, Member of the Audit, Nomination and Remuneration Committees, Effective April 1, 2026 Chemring Group PLC announced the appointment of Baroness Kate Rock as an independent non-executive director. Upon joining the Board, Kate will become the Senior Independent Director and a member of the Audit, Nomination and Remuneration Committees. She will join the Board with effect from April 1, 2026. Kate is an experienced non-executive director with a board portfolio covering technology, engineering, construction and infrastructure. Underpinned by a strong background in corporate communications and strategy, she combines deep engineering sector knowledge with a strategic understanding of how innovation and technology enhance productivity, together with wide-ranging experience working across government. On December 1, 2022, Kate was appointed Non-Executive Chair of the UK infrastructure solutions company Costain Group PLC. Since that time Costain has seen a near five-fold increase in its share price and has re-entered the FTSE 250 index. In September 2018, she joined the Board of FTSE 250 Keller Group plc (the world's largest geotechnical specialist contractor) and is now the Senior Independent Director, serving on the Audit & Risk, Nomination & Governance, Remuneration and Sustainability Committees. Having been appointed a Life Peer in 2015, she sat on the House of Lords Science and Technology Select Committee until January 2023. She was also a member of the House of Lords Select Committee on Artificial Intelligence from 2017 to 2018 and was Chair of the House of Lords Select Committee on Autism between January and November 2025. Until January 2023, Kate was a Board member of the world's first Centre for Data Ethics and Innovation and was, until November 2017, a non-executive director of Imagination Technologies plc, the former global FTSE 250 high technology company. Announcement • Feb 20
Chemring Group PLC Appoints Stephen King as Interim Senior Independent Director Chemring Group PLC announced that as previously announced, Fiona MacAulay, Senior Independent Director, will not be seeking re-election at today's Annual General Meeting. The process to identify a suitable candidate to replace her is progressing well. In the meantime, Stephen King, Non-Executive Director, has been appointed the Interim Senior Independent Director. Stephen will fulfil this role in addition to his role as Chair of the Audit Committee. Announcement • Dec 10
Chemring Group PLC, Annual General Meeting, Feb 20, 2026 Chemring Group PLC, Annual General Meeting, Feb 20, 2026. Announcement • Nov 10
Fiona Macaulay Not Stand for Re-Election to the Board of Chemring Group plc Chemring Group PLC announced Fiona MacAulay, Senior Independent Director, has informed the Board that she will not be seeking re-election at the Group's Annual General Meeting in February 2026. Fiona's second three-year term as a non-executive director would otherwise have expired on 2 June 2026. The Chairman and the Board of Directors wish to extend their due to Fiona for her considerable contribution to the Group. A process to identify a suitable candidate to replace her will now be instigated. Announcement • Oct 07
Chemring Group PLC to Report Fiscal Year 2025 Results on Dec 09, 2025 Chemring Group PLC announced that they will report fiscal year 2025 results on Dec 09, 2025 Announcement • Jun 30
Chemring Group PLC (LSE:CHG) agreed to acquire Landguard Nexus Limited for £20 million. Chemring Group PLC (LSE:CHG) agreed to acquire Landguard Nexus Limited for £20 million on June 30, 2025. The consideration will be satisfied by a £14 million cash payment on completion, funded from Chemring's existing bank facilities, and cash earnouts totaling up to £6 million subject to certain performance targets. The acquisition is expected to be marginally earnings enhancing in the year ending October 31, 2026. Following completion of the acquisition, the current owner-managers of Landguard are expected to remain with Chemring.
For the period ending January 31, 2025, Landguard Nexus Limited reported total revenue of £7 million.
Completion of the transaction is subject to approval under the UK National Investment and Security Act. Announcement • Jun 03
Chemring Group plc Announces Interim Dividend, Payable on September 5, 2025 Chemring Group PLC has declared an interim dividend in respect of the 2025 financial year of 2.7 pence (first half of 2024: 2.6 pence) per ordinary share which will be paid on 5 September 2025 to shareholders on the register on 15 August 2025. Announcement • Feb 26
Chemring Group PLC to Report First Half, 2025 Results on Jun 03, 2025 Chemring Group PLC announced that they will report first half, 2025 results on Jun 03, 2025 Announcement • Dec 20
Chemring Group PLC, Annual General Meeting, Feb 26, 2025 Chemring Group PLC, Annual General Meeting, Feb 26, 2025. Announcement • Dec 17
Chemring Group PLC Recommends Final Dividend for the Year Ended 31 October, 2024, Payable on 11 April 2025 The Board of Chemring Group PLC is recommending a final dividend in respect of the year to 31 October 2024 of 5.2 pence (2023: 4.6 pence) per ordinary share. The estimated cash value of this dividend is £14.5 million. With the interim dividend of 2.6 pence per share (2023: 2.3 pence), this results in a total dividend of 7.8 pence (2023: 6.9 pence) per ordinary share. If approved, the final dividend will be paid on 11 April 2025 to shareholders on the register on 21 March 2025. In accordance with accounting standards, this final dividend has not been recorded as a liability as at 31 October 2024. Announcement • Dec 05
Chemring Group Announces Board Changes Chemring announced that Andrew Davies, who has been a non-executive director since May 2016 and the Senior Independent Director since May 2020, will retire from the Board on 31 January 2025, having approached the end of his nine-year term, and will not therefore seek re-election at the 2025 Annual General Meeting. As previously indicated in the 2023 annual report, Fiona MacAulay, who has been a non-executive director since June 2020, will succeed Andrew as the Senior Independent Director. Announcement • Oct 17
Chemring Group PLC to Report Fiscal Year 2024 Results on Dec 17, 2024 Chemring Group PLC announced that they will report fiscal year 2024 results on Dec 17, 2024 Announcement • Jun 24
Chemring Group plc Announces Board Changes Chemring Group PLC announced the appointment of Tony Wood as an independent non-executive director and Chairman-designate. He joins the Board with effect from October 1, 2024 and will succeed Carl-Peter Forster as Chairman of the Board on 1 December 2024, following Carl-Peter's retirement on November 30, 2024. Carl-Peter joined the Board of Chemring on 1 May 2016 and was appointed Chairman on July 1, 2016. Since then he has successfully led the Group through a period of significant transformation as they have built a stronger, higher-quality and more resilient business. The investments made in both culture and infrastructure position the Group well to capitalise on its many opportunities. Tony is a member of the Board of Directors of Airbus SE, the CAC 40 aerospace and defence firm, and National Grid plc, an energy company operating in the UK and the US. From 2018-2022 he was Chief Executive of FTSE 100 Meggitt plc, where he led the operational and cultural transformation of the company. He brings to the Board significant engineering and sector experience having also been a Non-Executive Director and former President of ADS Group Limited, the trade association for the Aerospace, Defence, Security and Space sectors in the UK, from 2020-2023. Prior to joining Meggitt he spent 15 years at Rolls-Royce plc, latterly serving as President of Aerospace from 2013-2016. Tony holds a degree in Engineering from the Open University in the UK and a Master of Business Administration from INSEAD in France. He is a Fellow of the Royal Aeronautical Society and a Fellow of the Association for Project Management. Recent Insider Transactions • Mar 27
Group Chief Executive & Director recently sold UK£495k worth of stock On the 22nd of March, Michael Ord sold around 138k shares on-market at roughly UK£3.58 per share. This transaction amounted to 30% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth UK£669k. Michael has been a net seller over the last 12 months, reducing personal holdings by UK£1.2m. Upcoming Dividend • Mar 15
Upcoming dividend of UK£0.046 per share Eligible shareholders must have bought the stock before 21 March 2024. Payment date: 12 April 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of British dividend payers (6.1%). In line with average of industry peers (2.0%). Recent Insider Transactions • Jan 17
Group Chief Executive & Director recently sold UK£669k worth of stock On the 15th of January, Michael Ord sold around 192k shares on-market at roughly UK£3.48 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months. Announcement • Jan 10
Chemring Group PLC to Report First Half, 2024 Results on Jun 04, 2024 Chemring Group PLC announced that they will report first half, 2024 results on Jun 04, 2024 New Risk • Dec 20
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 33% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Reported Earnings • Dec 13
Full year 2023 earnings released: EPS: UK£0.13 (vs UK£0.17 in FY 2022) Full year 2023 results: EPS: UK£0.13 (down from UK£0.17 in FY 2022). Revenue: UK£472.6m (up 6.7% from FY 2022). Net income: UK£37.7m (down 21% from FY 2022). Profit margin: 8.0% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Aerospace & Defense industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 4% per year and the company’s share price has also increased by 4% per year. Announcement • Sep 12
Chemring Group PLC Provides Revenue Guidance for the Year Ending 31 October 2023 Chemring Group PLC provided revenue guidance for the year ending 31 October 2023. Expected fiscal year 2023 revenue is now fully covered by the order book and the outturn for the year ending 31 October 2023 remains in line with the Board's and current analyst expectations. Achieving full year expectations is subject to US Department of Defense ("US DoD") approval of certain countermeasure deliveries, representing c.£25m of revenue, that have already been manufactured and will be recognised once approval is received. Upcoming Dividend • Aug 10
Upcoming dividend of UK£0.023 per share at 2.0% yield Eligible shareholders must have bought the stock before 17 August 2023. Payment date: 08 September 2023. Payout ratio is a comfortable 43% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of British dividend payers (6.1%). Lower than average of industry peers (2.4%). Board Change • Jul 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 7 experienced directors. 1 highly experienced director. Independent Non Executive Director Alpna Amar was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Jun 13
Chemring Group plc Announces Appointment of Alpna Amar as an Independent Non-Executive Director with Immediate Effect Chemring Group PLC announced the appointment of Alpna Amar as an independent non-executive director. She will join the Board with immediate effect. Alpna (age 43) is currently Corporate Development Director of Kier Group plc and has been a member of Kier Group's Executive Committee since May 2021. A qualified Chartered Accountant, Alpna has over 22 years of corporate, operational and commercial finance, strategy, M&A and investor relations experience in both corporate and consulting positions. Prior to Kier Group she held senior investor relations and corporate development roles at global automotive suppliers, TI Fluid Systems plc and International Automotive Components Group SA. Alpna is a fellow of the Institute of Chartered Accountants of England and Wales and has a degree in Economics and Politics from Lancaster University. Upon joining the Board, Alpna Amar will become a member of the Audit and Nomination Committees. Reported Earnings • Jun 06
First half 2023 earnings released: EPS: UK£0.066 (vs UK£0.095 in 1H 2022) First half 2023 results: EPS: UK£0.066 (down from UK£0.095 in 1H 2022). Revenue: UK£212.1m (down 3.8% from 1H 2022). Net income: UK£18.7m (down 29% from 1H 2022). Profit margin: 8.8% (down from 12% in 1H 2022). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 2.9% growth forecast for the Aerospace & Defense industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 6% per year. Announcement • May 25
Chemring Group plc Announces Appointment of James Mortensen as Chief Financial Officer Chemring Group PLC announced appointment of James Mortensen as Chief Financial Officer. James has a proven track record in industrial, engineering and technology sectors with extensive experience in building and managing global, multi-disciplinary finance teams. He joins Chemring from Smiths Group plc ("Smiths"), the FTSE 100 engineering group where he has spent the last seven years. James joined the Smiths M&A team in 2016 and, having played a key role in scaling ventilator manufacturing during COVID for the UK Government, he became Chief Financial Officer of the $1.1bn revenue Smiths Medical Division in 2020. He held this role until the sale of Smiths Medical for $2.7bn in February 2022, having also prepared the business for a London listing. He is currently Group Head of Corporate Development with responsibility for sourcing, evaluating and executing acquisitions across the four major global markets where Smiths operate: Security & Defence, Aerospace, General Industry and Energy. Prior to Smiths James spent eight years at Smith & Nephew plc, the FTSE 100 medical technology company where he held progressively senior finance roles in the areas of group reporting, strategic planning and corporate finance. Having graduated from Bristol University James started his career at KPMG in their audit practice and is a fellow of the Institute of Chartered Accountants of England and Wales. James will take over from Andrew Lewis, who announced his intention to retire on 23 January 2023 and whose notice period runs until 22 January 2024. The Group is working with James to agree the date on which he will join Chemring. A further announcement will be made in due course. Buying Opportunity • Apr 25
Now 21% undervalued Over the last 90 days, the stock is up 3.4%. The fair value is estimated to be UK£3.62, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.1% over the last 3 years. Earnings per share has grown by 18%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings is also forecast to grow by 5.7% per annum over the same time period. Upcoming Dividend • Mar 16
Upcoming dividend of UK£0.038 per share at 2.0% yield Eligible shareholders must have bought the stock before 23 March 2023. Payment date: 14 April 2023. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (2.9%). Buying Opportunity • Mar 06
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 6.7%. The fair value is estimated to be UK£3.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.1% over the last 3 years. Earnings per share has grown by 18%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings is also forecast to grow by 5.8% per annum over the same time period. Buying Opportunity • Feb 14
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 6.3%. The fair value is estimated to be UK£3.64, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.1% over the last 3 years. Earnings per share has grown by 18%. For the next 3 years, revenue is forecast to grow by 4.8% per annum. Earnings is also forecast to grow by 6.2% per annum over the same time period. Announcement • Feb 01
Chemring Group PLC to Report Q2, 2023 Results on Jun 06, 2023 Chemring Group PLC announced that they will report Q2, 2023 results on Jun 06, 2023 Recent Insider Transactions • Jan 29
Independent Non-Executive Director recently bought UK£185k worth of stock On the 24th of January, Stephen King bought around 65k shares on-market at roughly UK£2.84 per share. This transaction increased Stephen's direct individual holding by 2x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold UK£2.6m more in shares than they bought in the last 12 months. Buying Opportunity • Jan 09
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 8.3%. The fair value is estimated to be UK£3.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.1% over the last 3 years. Earnings per share has grown by 18%. For the next 3 years, revenue is forecast to grow by 4.8% per annum. Earnings is also forecast to grow by 6.3% per annum over the same time period. Recent Insider Transactions • Dec 22
CFO & Director recently sold UK£1.0m worth of stock On the 19th of December, Andrew Lewis sold around 339k shares on-market at roughly UK£3.01 per share. This transaction amounted to 53% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Andrew has been a net seller over the last 12 months, reducing personal holdings by UK£1.6m. Reported Earnings • Dec 15
Full year 2022 earnings released: EPS: UK£0.17 (vs UK£0.15 in FY 2021) Full year 2022 results: EPS: UK£0.17 (up from UK£0.15 in FY 2021). Revenue: UK£442.8m (up 13% from FY 2021). Net income: UK£47.4m (up 14% from FY 2021). Profit margin: 11% (in line with FY 2021). Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Aerospace & Defense industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Announcement • Dec 13
Chemring Group PLC, Annual General Meeting, Mar 15, 2023 Chemring Group PLC, Annual General Meeting, Mar 15, 2023. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. Independent Non-Executive Director Fiona MacAulay was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. Independent Non-Executive Director Fiona MacAulay was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Aug 11
Upcoming dividend of UK£0.019 per share Eligible shareholders must have bought the stock before 18 August 2022. Payment date: 09 September 2022. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of British dividend payers (5.1%). Lower than average of industry peers (3.0%). Recent Insider Transactions • Jul 15
Group Legal Director recently sold UK£58k worth of stock On the 11th of July, Sarah Ellard sold around 18k shares on-market at roughly UK£3.24 per share. In the last 3 months, there was an even bigger sale from another insider worth UK£64k. Insiders have been net sellers, collectively disposing of UK£1.2m more than they bought in the last 12 months. Reported Earnings • Jun 09
First half 2022 earnings released First half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down UK£21.4m from profit in 1H 2021). Profit margin: (down from 11% in 1H 2021). The decrease in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 7.9%, compared to a 12% growth forecast for the industry in the United Kingdom. Recent Insider Transactions • Mar 17
Group Finance Director & Director recently sold UK£60k worth of stock On the 14th of March, Andrew Lewis sold around 18k shares on-market at roughly UK£3.34 per share. This was the largest sale by an insider in the last 3 months. This was Andrew's only on-market trade for the last 12 months. Upcoming Dividend • Mar 03
Upcoming dividend of UK£0.032 per share Eligible shareholders must have bought the stock before 10 March 2022. Payment date: 31 March 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of British dividend payers (4.6%). Lower than average of industry peers (3.2%). Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment improved over the past week After last week's 20% share price gain to UK£3.10, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Aerospace & Defense industry in the United Kingdom. Total returns to shareholders of 110% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at UK£4.73 per share. Reported Earnings • Dec 15
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Full year 2021 results: EPS: UK£0.15 (up from UK£0.12 in FY 2020). Revenue: UK£393.3m (down 2.3% from FY 2020). Net income: UK£41.5m (up 20% from FY 2020). Profit margin: 11% (up from 8.6% in FY 2020). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 4.1%. Over the next year, revenue is forecast to grow 8.2%, compared to a 11% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Aug 12
Upcoming dividend of UK£0.016 per share Eligible shareholders must have bought the stock before 19 August 2021. Payment date: 10 September 2021. Trailing yield: 1.3%. Lower than top quartile of British dividend payers (3.8%). Lower than average of industry peers (3.6%). Board Change • Jul 31
High number of new directors Non-Executive Director Fiona MacAulay was the last director to join the board, commencing their role in 2020. Recent Insider Transactions • Jul 22
Group Chief Executive & Director recently sold UK£466k worth of stock On the 19th of July, Michael Ord sold around 165k shares on-market at roughly UK£2.82 per share. This was the largest sale by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months. Reported Earnings • Jun 05
First half 2021 earnings released: EPS UK£0.076 (vs UK£0.058 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: UK£198.5m (up 3.9% from 1H 2020). Net income: UK£21.4m (up 31% from 1H 2020). Profit margin: 11% (up from 8.5% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Mar 25
Upcoming dividend of UK£0.026 per share Eligible shareholders must have bought the stock before 01 April 2021. Payment date: 23 April 2021. Trailing yield: 1.5%. Lower than top quartile of British dividend payers (4.4%). Lower than average of industry peers (4.0%). Is New 90 Day High Low • Jan 08
New 90-day high: UK£3.03 The company is up 19% from its price of UK£2.56 on 09 October 2020. The British market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Aerospace & Defense industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£2.40 per share. Is New 90 Day High Low • Dec 16
New 90-day high: UK£3.00 The company is up 15% from its price of UK£2.60 on 17 September 2020. The British market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Aerospace & Defense industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£2.41 per share. Reported Earnings • Dec 16
Full year 2020 earnings released: EPS UK£0.12 The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: UK£402.5m (up 20% from FY 2019). Net income: UK£34.7m (up 50% from FY 2019). Profit margin: 8.6% (up from 6.9% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Analyst Estimate Surprise Post Earnings • Dec 16
Revenue beats expectations Revenue exceeded analyst estimates by 3.3%. Over the next year, revenue is forecast to grow 3.9%, compared to a 9.1% growth forecast for the Aerospace & Defense industry in the United Kingdom.